Middle East and Africa Botulinum Toxin Market Overview and Growth by 2030

Historic Data: 2020-2022   |   Base Year: 2022   |   Forecast Period: 2022-2030

Middle East and Africa Botulinum Toxin Market Size and Forecasts (2020 - 2030), Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Botox, Dysport, Xeomin, and Others), Application (Medical and Aesthetic), and End User (Specialty and Dermatology Clinics, Hospitals and Clinics, and Others)

  • Report Date : Sep 2025
  • Report Code : TIPRE00033005
  • Category : Life Sciences
  • Status : Data Released
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Middle East and Africa botulinum toxin market size is expected to reach US$ 453.55 million by 2030 from US$ 172.57 million in 2022. The market is estimated to record a CAGR of 12.8% from 2022 to 2030.

Market Insights and Analyst View:

Botox injections block chemical signals from nerves that cause muscle contraction. The injections relax the facial muscles that cause frown lines and other facial wrinkles. Botox is a drug developed from a toxin produced by the bacterium Clostridium botulinum. There are various types of botulinum toxin, with types A and B being commonly used for medical and cosmetic purposes.

Botulinum toxin is used for the treatment of various medical conditions, including chronic migraines, muscle spasms, and certain neurological disorders. It is also widely known for its cosmetic applications, particularly in the form of Botox injections, to reduce the appearance of facial wrinkles and fine lines. In medical and cosmetic settings, botulinum toxin is injected directly into specific muscles. The toxin blocks nerve signals in the injected muscles, causing temporary muscle paralysis. The effects of botulinum toxin are temporary, typically lasting for a few months. Repeat injections are often necessary to maintain the desired results.

While botulinum toxin is generally considered safe when administered by medical professionals in appropriate doses, there can be side effects and risks. Common side effects include temporary bruising and muscle weakness. It is crucial for individuals considering botulinum toxin treatments to consult with qualified healthcare professionals to assess suitability and discuss potential risks and benefits. Additionally, regulations regarding the use of botulinum toxin may vary by country and region.

The Middle East & Africa botulinum toxin market is growing rapidly due to a number of factors, such as increasing disposable incomes in the Middle East, rising awareness regarding the benefits of botulinum toxin, growing prevalence of neurological disorders, and increasing applications of botulinum toxin in the treatment of various diseases. The market is also expected to benefit from the development of new and innovative botulinum toxin products and applications. However, side effects associated with the botulinum toxin hamper the Middle East and Africa botulinum toxin market growth.

Growth Drivers and Challenges:

Rising Awareness Regarding Benefits of Botulinum Toxin Drives Middle East and Africa Botulinum Toxin Market Growth

People in the Middle East are willing to spend money on aesthetic procedures due to a rise in disposable incomes. Botulinum toxin injections are a popular aesthetic procedure as they are relatively quick, easy, and effective. People in the Middle East are becoming more aware of the benefits of botulinum toxin injections, both for aesthetic and therapeutic purposes. Botulinum toxin injections can be used to treat wrinkles, frown lines, and crow's feet. Botulinum toxin is an effective and safe treatment for various neurological disorders, including spasticity, dystonia, and migraine headaches. The rising prevalence of neurological disorders in the Middle East drives demand for botulinum toxin injections. Botulinum toxin injections are increasingly being used to treat hyperhidrosis or excessive sweating. Hyperhidrosis can be a debilitating condition that can affect a person's social and professional life. Botulinum toxin injections can provide effective relief from hyperhidrosis symptoms. Minimally invasive procedures are becoming increasingly popular, as they are associated with less pain, scarring, and recovery time than traditional surgical procedures. Botulinum toxin injections are minimally invasive procedures that can be performed in a doctor's office. Owing to the factors mentioned above, the Middle East and Africa botulinum toxin market is expected to grow in the coming years.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Middle East and Africa Botulinum Toxin Market: Strategic Insights

Middle East and Africa Botulinum Toxin Market
  • Market Size 2022
    US$ 172.57 Million
  • Market Size 2030
    US$ 453.55 Million

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market SegmentProduct
  • Botox
  • Dysport
  • Xeomin
Market SegmentApplication
  • Medical and Aesthetic
Market Segmentand End User
  • Specialty and Dermatology Clinics
  • Hospitals and Clinics
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Segmentation and Scope:

The “Middle East & Africa Botulinum Toxin Market” is segmented on the basis of product, application, end-user, and Country. 

Based on product, the Middle East and Africa botulinum toxin market is segmented into Botox, Dysport, Xeomin, and others. The Botox segment held the largest market share in 2022 and is expected to retain its dominance during the forecast period. By application, the market is bifurcated into medical and aesthetic. The medical segment held a larger market share in 2022. However, the aesthetic segment is anticipated to register a significant CAGR during the forecast period. The botulinum toxin market, by end-user, is segmented into hospitals and clinics, specialty and dermatology clinics, and others. The specialty and dermatology clinics segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period.

Segmental Analysis:

The medical segment led the Middle East and Africa botulinum toxin market in 2022 and is expected to retain its dominance during the forecast period. Botulinum toxin is widely used to treat medical conditions such as chronic migraine, adult spasticity, pediatric spasticity, and others. For migraine conditions, onabotulinumtoxin A is a prescription medication injected into the muscle with clinical effects such as preventing headaches among adults with chronic migraine.

Botulinum toxin is one of the most versatile agents in the aesthetic field. It has been used for numerous applications, such as the treatment of glabellar and forehead lines, eyebrow repositioning, and periorbital wrinkles.

Regional Analysis:

Based on country, the Middle East and Africa botulinum toxin market is segmented into Saudi Arabia, the UAE, South Africa, Lebanon, Oman, Jordan, Qatar, Kuwait, Bahrain, and the Rest of the Middle East & Africa. Saudi Arabia held the largest market share, followed by the UAE.

Saudi Arabia is one of the largest markets in the Middle East and Africa regarding population and economy. In recent years, there has been an increase in the number of cosmetic procedures, either surgical or non-surgical. According to a study conducted by the International Society of Aesthetic Plastic Surgeons, Saudi Arabia ranks 22nd among the top 25 countries with the highest rates of cosmetic procedures in the world. Acceptance of less invasive procedures such as botulinum toxin, dermal fillers, laser, and chemical peels increased among middle-aged women to have a natural look without significant downtime.

Furthermore, increasing product approvals for treating glabellar lines is expected to impact the Middle East and Africa Botulinum toxin market positively. In October 2022, Daewoong Pharmaceutical announced that it had obtained product approval from the Saudi Arabian and Ukrainian governments for Nabota, a botulinum toxin (BTX) product.

Therefore, the factors mentioned above fuel the growth of the Middle East and Africa Botulinum toxin market in Saudi Arabia.

Middle East and Africa Botulinum Toxin Market Report Scope

Report Attribute Details
Market size in 2022 US$ 172.57 Million
Market Size by 2030 US$ 453.55 Million
Global CAGR (2022 - 2030) 12.8%
Historical Data 2020-2022
Forecast period 2022-2030
Segments Covered By Product
  • Botox
  • Dysport
  • Xeomin
By Application
  • Medical and Aesthetic
By and End User
  • Specialty and Dermatology Clinics
  • Hospitals and Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Merz Pharma GmbH & Co. KGaA
  • AbbVie Inc.
  • Revance Therapeutics Inc.
  • Ipsen SA
  • List Biological Labs Inc.
  • Medytox Inc.
  • Evolus Inc.
  • Hugel Inc.
  • Lanzhou Institute of Biological Products Co. Ltd.
  • Competitive Landscape and Key Companies:

    Organic and inorganic growth strategies have characterized developments in the Middle East and Africa botulinum toxin market. Various companies focus on organic growth strategies such as launches, expansion, enhancement, and relocation. Inorganic growth strategies witnessed in the market were mergers & acquisitions, partnerships, and collaborations. These activities have paved the way for the expansion of businesses and the customer base of Middle Eastern and African botulinum toxin market players.

    • In February 2022, Merz Therapeutics announced that it will expand its strategic partnership with Vensica Therapeutics as the Merz Group invests up to US$3 million in the Israeli start-up. This investment follows the strategic license and collaboration agreement signed in 2021 to utilize Merz’s botulinum neurotoxin A (XEOMIN) for the innovative ultrasound-assisted delivery catheter of Vensica. Merz is thus executing its contractually agreed option to participate in Vensica’s Series C financing round and invest further in the start-up. 
    • In August 2021, Merz Therapeutics and the Israeli start-up Vensica Therapeutics Ltd., a urology company, announced that they have entered into a strategic license and collaboration agreement to deliver botulinum neurotoxin A (XEOMIN) to the bladder wall by using Vensica’s innovative ultrasound-assisted delivery catheter. By this, Merz Therapeutics becomes the exclusive toxin supplier of any needleless application for urological indications, such as overactive bladder, neurogenic bladder, interstitial cystitis, and other urology indications.

    Company Profiles

    • Merz Pharma GmbH & Co KGaA
    • AbbVie Inc
    • Revance Therapeutics Inc
    • Ipsen SA
    • Medytox Inc
    • Evolus Inc
    • Hugel Inc
    • Lanzhou Institute of Biological Products Co Ltd
    • Gufic
    • Metabiologics, Inc.

    Frequently Asked Questions

    What is the Botulinum toxins?

    Answer: Botox injections block chemical signals from nerves that cause muscle contraction. The Botox injections relax the facial muscles that cause frown lines and other facial wrinkles. Botox is a drug developed from a toxin produced by the bacterium Clostridium botulinum. There are various types of botulinum toxin, with types A and B being commonly used for medical and cosmetic purposes.

    Which segment by application is dominating the Middle East and Africa Botulinum Toxins market?

    Answer: - The Middle East and Africa botulinum toxin market by application is segmented into medical and aesthetic. The medical segment held the largest share of the Middle East and Africa Botulinum Toxin market, and it is anticipated to register the highest CAGR.

    What are the driving factors for the Middle East and Africa Botulinum toxins market across the world?

    Answer: The factors that are driving the growth of market are growth are increasing disposable incomes in the Middle East, increasing awareness of the benefits of botulinum toxin, growing prevalence of neurological disorders, and increasing applications of botulinum toxin in the treatment of various diseases.

    Which segment by product is dominating the Middle East and Africa Botulinum Toxins market?

    Answer: - The Middle East and Africa botulinum toxin market by product is segmented into Botox, Dysport, Xemoin, and others. The Botox segment held the largest share of the Middle East and Africa Botulinum Toxin market, and it is anticipated to register the highest CAGR.

    Who are the major players in market the Middle East and Africa Botulinum Toxins market?

    Answer: - The botulinum toxins market majorly consists of the players such as Merz Pharma GmbH & Co KGaA, AbbVie Inc, Revance Therapeutics Inc, Ipsen SA, Medytox Inc, Evolus Inc, Hugel Inc, Lanzhou Institute of Biological Products Co Ltd, Gufic, and Metabiologics, Inc.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    The List of Companies - Middle East and Africa Botulinum Toxin Market

    1. Merz Pharma GmbH & Co. KGaA
    2. AbbVie Inc.
    3. Revance Therapeutics Inc.
    4. Ipsen SA
    5. List Biological Labs Inc.
    6. Medytox Inc.
    7. Evolus Inc.
    8. Hugel Inc.
    9. Lanzhou Institute of Biological Products Co. Ltd.
    10. Supernus Pharmaceuticals
    11. Gufic

     

    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo